Rituximab bioavailability in primary membranous nephropathy-Reference-Cited by-同舟云学术

Rituximab bioavailability in primary membranous nephropathy

Published:2019-03-30 Issue:8 Volume:34 Page:1423-1425
ISSN:0931-0509
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:

Author:

Boyer-Suavet Sonia¹,Andreani Marine¹,Cremoni Marion²,Brglez Vesna¹²,Benzaken Sylvia²,Bernard Ghislaine²,Nachman Patrick³,Esnault Vincent¹,Seitz-Polski Barbara¹²⁴

Affiliation:

1. Service de Néphrologie-Dialyse-Transplantation, Hôpital Pasteur, CHU de Nice, Université de Nice-Sophia Antipolis, Nice, France

2. Laboratoire d’Immunologie, Hôpital l’Archet, CHU de Nice, Université de Nice-Sophia Antipolis, Nice, France

3. Division of Renal Diseases and Hypertension, University of Minnesota, Minneapolis, MN, USA

4. CNRS and Université de Nice-Sophia Antipolis, Institut de Pharmacologie Moléculaire et Cellulaire, UMR 7275, Valbonne Sophia-Antipolis, France

Funder

the Centre Hospitalier Universitaire de Nice

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ndt/article-pdf/34/8/1423/29096776/gfz041.pdf

Reference17 articles.

1. Mechanism of action of rituximab;Maloney;Anticancer Drugs,2001

2. Anti-CD20 monoclonal antibodies: historical and future perspectives;Lim;Haematologica,2010

3. Rituximab for idiopathic membranous nephropathy;Remuzzi;Lancet,2002

4. Rituximab treatment of idiopathic membranous nephropathy;Fervenza;Kidney Int,2008

5. Rituximab therapy in idiopathic membranous nephropathy: a 2-year study;Fervenza;Clin J Am Soc Nephrol,2010

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel approaches to primary membranous nephropathy: Beyond the KDIGO guidelines;European Journal of Pharmacology;2024-11

2. B cell dysregulation and depletion therapy in primary membranous nephropathy: Prospects and potential challenges;International Immunopharmacology;2024-10

3. Membranous Nephropathy: Updates on Management;Advances in Kidney Disease and Health;2024-07

4. Dosing optimization of rituximab for primary membranous nephropathy by population pharmacokinetic and pharmacodynamic study;Frontiers in Pharmacology;2024-03-26

5. Novel factors potentially initiating acute antibody‐mediated rejection in pig kidney xenografts despite an efficient immunosuppressive regimen;Xenotransplantation;2024-03